Anebulo Pharmaceuticals Files 8-K
Ticker: ANEB · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1815974
| Field | Detail |
|---|---|
| Company | Anebulo Pharmaceuticals, Inc. (ANEB) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
Anebulo Pharma filed an 8-K on 7/23/25. Basic corporate info updated.
AI Summary
Anebulo Pharmaceuticals, Inc. filed an 8-K on July 23, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734, and its telephone number is (512).
Why It Matters
This 8-K filing provides an update on Anebulo Pharmaceuticals' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Anebulo Pharmaceuticals, Inc. (company) — Registrant
- July 23, 2025 (date) — Date of earliest event reported
- 1017 Ranch Road 620 South, Suite 107 (address) — Principal Executive Offices
- Lakeway, TX (location) — City and State of Principal Executive Offices
- 78734 (zip_code) — Zip Code of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Anebulo Pharmaceuticals, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of July 23, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 23, 2025.
Where are Anebulo Pharmaceuticals, Inc.'s principal executive offices located?
Anebulo Pharmaceuticals, Inc.'s principal executive offices are located at 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734.
What is the telephone number for Anebulo Pharmaceuticals, Inc.?
The telephone number for Anebulo Pharmaceuticals, Inc., including area code, is (512).
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding Anebulo Pharmaceuticals, Inc. (ANEB).